238 related articles for article (PubMed ID: 26109805)
1. β-2 Adrenergic receptor gene polymorphism and response to propranolol in cirrhosis.
Kong DR; Wang JG; Sun B; Wang MQ; Chen C; Yu FF; Xu JM
World J Gastroenterol; 2015 Jun; 21(23):7191-6. PubMed ID: 26109805
[TBL] [Abstract][Full Text] [Related]
2. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.
Turnes J; Hernández-Guerra M; Abraldes JG; Bellot P; Oliva R; García-Pagán JC; Bosch J
Hepatology; 2006 Jan; 43(1):34-41. PubMed ID: 16374847
[TBL] [Abstract][Full Text] [Related]
3. Influence of CYP2D6 and β2-adrenergic receptor gene polymorphisms on the hemodynamic response to propranolol in Chinese Han patients with cirrhosis.
Zhang F; Duan X; Zhang M; Li Z; He Q; Wang Y; Miao C; Zhong W; Zou X; Zhuge Y
J Gastroenterol Hepatol; 2016 Apr; 31(4):829-34. PubMed ID: 26489037
[TBL] [Abstract][Full Text] [Related]
4. Propranolol reduces variceal pressure and wall tension in schistosomiasis presinusoidal portal hypertension.
Farias AQ; Kassab F; da Rocha EC; Dos Santos Bomfim V; Vezozzo DC; Bittencourt PL; Carrilho FJ
J Gastroenterol Hepatol; 2009 Dec; 24(12):1852-6. PubMed ID: 19686417
[TBL] [Abstract][Full Text] [Related]
5. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
6. Prognostic markers in patients who have recovered from an acute variceal bleeding: role of HVPG measurement.
Bañares R; Catalina MV; Ripoll C; Rincón D
Dis Markers; 2011; 31(3):165-9. PubMed ID: 22045402
[No Abstract] [Full Text] [Related]
7. Effects of propranolol or propranolol plus isosorbide-5-mononitrate on variceal pressure in schistosomiasis.
Kong DR; Ma C; Wang M; Wang JG; Chen C; Zhang L; Hao JH; Li P; Xu JM
World J Gastroenterol; 2013 Jul; 19(26):4228-33. PubMed ID: 23864788
[TBL] [Abstract][Full Text] [Related]
8. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.
Sarin SK; Lamba GS; Kumar M; Misra A; Murthy NS
N Engl J Med; 1999 Apr; 340(13):988-93. PubMed ID: 10099140
[TBL] [Abstract][Full Text] [Related]
9. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
Feu F; Bordas JM; Luca A; García-Pagán JC; Escorsell A; Bosch J; Rodés J
Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy.
Escorsell A; Bordas JM; Feu F; García-Pagán JC; Ginès A; Bosch J; Rodés J
Gastroenterology; 1997 Nov; 113(5):1640-6. PubMed ID: 9352867
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J
Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
Zoller WG; Gross M
Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
[TBL] [Abstract][Full Text] [Related]
14. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
[TBL] [Abstract][Full Text] [Related]
15. Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
Sharma P; Kumar A; Sharma BC; Sarin SK
Aliment Pharmacol Ther; 2009 Jul; 30(1):48-60. PubMed ID: 19392862
[TBL] [Abstract][Full Text] [Related]
16. [The effect of propranolol on portal hypertension].
Kovacević N; Tomić D; Perisić-Savić M; Grbić R
Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814
[TBL] [Abstract][Full Text] [Related]
17. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT.
García-Pagán JC; Morillas R; Bañares R; Albillos A; Villanueva C; Vila C; Genescà J; Jimenez M; Rodriguez M; Calleja JL; Balanzó J; García-Durán F; Planas R; Bosch J;
Hepatology; 2003 Jun; 37(6):1260-6. PubMed ID: 12774003
[TBL] [Abstract][Full Text] [Related]
18. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
Laleman W; Nevens F
Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837
[TBL] [Abstract][Full Text] [Related]
19. Clinical vs haemodynamic response to drugs in portal hypertension.
McCormick PA; Patch D; Greenslade L; Chin J; McIntyre N; Burroughs AK
J Hepatol; 1998 Jun; 28(6):1015-9. PubMed ID: 9672178
[TBL] [Abstract][Full Text] [Related]
20. Liver volume index predicts the risk of esophageal variceal hemorrhage in cirrhotic patients on propranolol prophylaxis.
Kim BH; Chung JW; Lee CS; Jang ES; Jeong SH; Kim N; Kim JW
Korean J Intern Med; 2019 Nov; 34(6):1233-1243. PubMed ID: 30759966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
